Development and validation of an LC-MS/MS procedure for environmental monitoring of eight cytostatic drugs in pharmacies

International Journal of Environmental Analytical Chemistry

Volumn 91, Issue 12, 2011, Pages 1178-1190

  Tuerk, Jochen ^a,b   Kiffmeyer, Thekla K ^a   Hadtstein, Claudia ^c   Heinemann, André ^d   Hahn, Moritz ^e   Stuetzer, Hartmut ^e   Kuss, Heinz Martin ^b   Eickmann, Udo ^d  

^a Institute of Energy and Environmental Technology IUTA   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Institute of Applied Pharmacy Cologne eV (IfAP)   (Germany)

^d BGW   (Germany)

^e IMSIE   (Germany)

Author keywords

Cytostatic drugs; Environmental monitoring; Liquid chromatography mass spectrometry; Occupational exposure; Surface contamination; Wipe samples

Indexed keywords

CYTOSTATIC; ENVIRONMENTAL MONITORING; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; SURFACE CONTAMINATION; WIPE SAMPLES;

ENVIRONMENTAL ENGINEERING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; TISSUE;

DRUG PRODUCTS;

EID: 84855502606     PISSN: 03067319     EISSN: 10290397     Source Type: Journal    
DOI: 10.1080/03067319.2010.494769     Document Type: Article

References (45)

1. C. Minoia, R. Turci, C. Sottani, A. Schiavi, L. Perbellini, S. Angeleri, F. Draicchio, and P. Apostoli, Rapid Commun Mass Spectrom 12, 1485 (1998).
2. G. Schmaus, R. Schierl, and S. Funck, Am. J. Health Syst. Pharm. 59, 956 (2002).
3. R. Turci, C. Sottani, G. Spagnoli, and C. Minoia, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 789, 169 (2003).
4. Occupational Safety and Health Information Series (Occupational Safety and Health Service, Department of Labour, Wellington, New Zealand, 1997).
5. HSE Information Sheet MISC 615: Safe Handling of Cytotoxic Drugs (Health and Safety Executive, Sudbury, Suffolk, UK, 2003).
6. NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and other Hazardous Drugs in Healthcare Settings (NIOSH - National Institute for Occupational Health and Safety, Cincinnati, OH, USA, 2004).
7. A. Heinemann, BGW topic: Cytostatic drugs in the health service. Information for safe handling of cytostatic drugs (M620) (Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege - BGW, Hamburg, Germany, 2009).
8. T.A. Connor, P.J. Sessink, B.R. Harrison, J.R. Pretty, B.G. Peters, R.M. Alfaro, A. Bilos, G. Beckmann, M.R. Bing, L.M. Anderson, and R. Dechristoforo, Am. J. Health Syst. Pharm. 62, 475 (2005).
9. G. Dranitsaris, M. Johnston, S. Poirier, T. Schueller, D. Milliken, E. Green, and B. Zanke, J. Oncol. Pharm. Pract. 11, 69 (2005).
10. E.E.M. Brouwers, A.D.R. Huitema, E.N. Bakker, J.W. Douma, K.J.M. Schimmel, G. van Weringh, P.J. de Wolf, J.H.M. Schelens, and J.H. Beijnen, Int. Arch. Occup. Environ. Health 80, 689 (2007).
11. M. Hedmer, H. Tinnerberg, A. Axmon, and B.A.G. Jonsson, Int. Arch. Occup. Environ. Health 81, 899 (2008).
12. T.H. Connor and M.A. McDiarmid, CA Cancer J. Clin. 56, 354 (2006).
13. IARC, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Supplement 7 (Lyon, France, 1987).
14. P.J. Sessink, M.M. Scholtes, R.B. Anzion, and R.P. Bos, J. Chromatogr. 616, 333 (1993).
15. C. Sottani, R. Turci, L. Perbellini, and C. Minoia, Rapid Communications in Mass Spectrometry 12, 1063 (1998).
16. M.E. de Jonge, S.M. van Dam, M.J. Hillebrand, H. Rosing, A.D. Huitema, S. Rodenhuis, and J.H. Beijnen, J. Mass Spectrom. 39, 262 (2004).
17. D. Kasel, A. Jetter, S. Harlfinger, W. Gebhardt, and U. Fuhr, Rapid Commun Mass Spectrom. 18, 1472 (2004).
18. M. Hedmer, A. Georgiadi, E.R. Bremberg, B.A. Jonsson, and S. Eksborg, Ann. Occup. Hyg. 49, 629 (2005).
19. A. Barbieri, L. Sabatini, P. Indiveri, R. Bonfiglioli, V. Lodi, and F.S. Violante, Rapid Commun. Mass Spectrom. 20, 1889 (2006).
20. C. Sottani, G. Tranfo, P. Faranda, and C. Minoia, Rapid Commun. Mass Spectrom. 19, 2794 (2005).
21. P.J. Sessink, K.A. Boer, A.P. Scheefhals, R.B. Anzion, and R.P. Bos, Int. Arch. Occup. Environ. Health 64, 105 (1992).
22. R.R. Larson, M.B. Khazaeli, and H.K. Dillon, Am. J. Health Syst. Pharm. 59, 270 (2002).
23. B. Favier, L. Gilles, C. Ardiet, and J. Francois, J. Oncol. Pharm. Pract. 9, 15 (2003).
24. M. Kubo, H. Sasabe, and T. Shimizu, J. Chromatogr. 564, 137 (1991).
25. L. Thiberville, P. Compagnon, N. Moore, G. Bastian, M.O. Richard, M.F. Hellot, C. Vincent, M.M. Kannass, S. Dominique, and C. Thuillez, Cancer Chemother. Pharmacol. 35, 64 (1994).
26. S. Funck, Ph.D. thesis, Ludwig-Maximilians University Munich, 2003.
27. G. Remaud, M. Boisdron-Celle, A. Morel, and A. Gamelin, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 824, 153 (2005).
28. A. Salvador, L. Millerioux, and A. Renou, Chromatographia 63, 609 (2006).
29. P.J. Sessink, N.S. Friemel, R.B. Anzion, and R.P. Bos, Int. Arch. Occup. Environ. Health 65, 401 (1994).
30. L. Floridia, A.M. Pietropaolo, M. Tavazzani, F.M. Rubino, and A. Colombi, J. Chromatogr. B Biomed. Sci. Appl. 726, 95 (1999).
31. L. Sabatini, A. Barbieri, M. Tosi, and F.S. Violante, J. Mass Spectrom. 40, 669 (2005).
32. R. Turci, G. Micoli, and C. Minoia, Rapid Commun. Mass Spectrom. 14, 685 (2000).
33. C. Sottani, R. Turci, G. Micoli, M.L. Fiorentino, and C. Minoia, Rapid Commun. Mass Spectrom. 14, 930 (2000).
34. F.M. Rubino, L. Floridia, A.M. Pietropaolo, M. Tavazzani, and A. Colombi, Med. Lav. 90, 572 (1999).
35. L. Kovalova, C.S. McArdell, and J. Hollender, J. Chromatogr. A 1216, 1100 (2009).
36. C. Sottani, R. Turci, R. Schierl, R. Gaggeri, A. Barbieri, F.S. Violante, and C. Minoia, Rapid Commun. Mass Spectrom. 21, 1289 (2007).
37. J. Tuerk, M. Reinders, D. Dreyer, T.K. Kiffmeyer, K.G. Schmidt, and H.M. Kuss, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 831, 72 (2006).
38. W. Fransman, D. Huizer, J. Tuerk, and H. Kromhout, Int. Arch. Occup. Environ. Health 80, 396 (2007).
39. M. Hedmer, B.A.G. Jonsson, and O. Nygren, J. Environ. Monit. 6, 979 (2004).
40. J. Yoshida, G. Tei, C. Mochizuki, Y. Masu, S. Koda, and S. Kumagai, Ann. Occup. Hyg. 53, 153 (2009).
41. M. Zeedijk, B. Greijdanus, F.B. Steenstra, and D.R.A. Uges, Eur. J. Hosp. Pharm. Sci. 11, 18 (2005).
42. J.F. Bussieres, Y. Theoret, S. Prot-Labarthe, and D. Larocque, Am. J. Health Syst. Pharm. 64, 531 (2007).
43. A. Pethran, R. Schierl, and G. Schmaus, Krankenhauspharmazie 22, 11 (2001).
44. A. Jacolot, Ph. Arnaud, D. Lecompte, S. Alamercery, E. Caroff, C. Naveau, Th. Guillot, M. Bousselet, and F. Brion, Int. J. Pharm. 128, 283 (1996).
45. I. Kraemer, in Pharmaceutical Photostability and Stabilization Technology, edited by Joseph T. Piechocki and Karl Thoma (Informa Healthcare, New York, NY, 2007), pp. 397-427.